Austrianova Secures Investment from Checkmate Capital
March 01, 2023 12:00 ET
|
SG Austria Pte Ltd
SINGAPORE, March 02, 2023 (GLOBE NEWSWIRE) -- SG Austria (“Austrianova”), a leading provider of cell biological products and services, today announced that Checkmate Capital Group (“Checkmate...
PharmaCyte Biotech Officially Begins Development of Diabetes Treatment With First Preclinical Study
February 04, 2015 09:00 ET
|
PharmaCyte Biotech, Inc.
NEW YORK, NY--(Marketwired - February 04, 2015) - PharmaCyte Biotech, Inc. (OTCQB: PMCB) officially moved beyond the discussion of a diabetes treatment to planting its flag in the multi-billion dollar...